Literature DB >> 22591192

Rectal hypersensitivity as hallmark for irritable bowel syndrome: defining the optimal cutoff.

S Ludidi1, J M Conchillo, D Keszthelyi, M Van Avesaat, J W Kruimel, D M Jonkers, A A M Masclee.   

Abstract

BACKGROUND: Visceral hypersensitivity is a frequently observed hallmark of irritable bowel syndrome (IBS). Studies have reported differently about the presence of visceral hypersensitivity in IBS resulting from lack of standardization of the barostat procedure and due to different criteria used to assess hypersensitivity. We aimed to calculate the optimal cutoff to detect visceral hypersensitivity in IBS.
METHODS: A total of 126 IBS patients and 30 healthy controls (HC) were included for assessment of visceroperception by barostat. Pain perception was assessed on a visual analogue scale (VAS). ROC-curves were used to calculate optimal discriminative cutoff (pressure and VAS-score) between IBS patients and HC to define hypersensitivity. Furthermore, pain perception to distension sequences below the pressure threshold for hypersensitivity was defined as allodynia. KEY
RESULTS: Irritable bowel syndrome patients showed increased visceroperception compared to HC. Thresholds for first sensation and first pain were lower in IBS patients VS HC (P < 0.01). ROC-curves showed optimal discrimination between IBS patients and HC at 26 mmHg with a VAS cutoff ≥20 mm. Using this criterion, hypersensitivity percentages were 63.5% and 6.6% in IBS patients and HC, respectively. No significant differences were observed between IBS subtypes. Allodynia was found in a small number of patients (11%). CONCLUSIONS &amp; INFERENCES: Optimal cutoff for visceral hypersensitivity was found at pressure 26 mmHg with a VAS ≥20 mm, resulting in 63.5% of IBS patients being hypersensitive and 11% being allodynic. Standardization of barostat procedures and defining optimal cutoff values for hypersensitivity is warranted when employing rectal barostat measurements for research or clinical purposes.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22591192     DOI: 10.1111/j.1365-2982.2012.01926.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  20 in total

1.  Identification of experimental bladder sensitivity among dysmenorrhea sufferers.

Authors:  Kevin M Hellman; Avisek Datta; Nicole D Steiner; Julia N Kane Morlock; Ellen F Garrison; Daniel J Clauw; Frank F Tu
Journal:  Am J Obstet Gynecol       Date:  2018-04-25       Impact factor: 8.661

2.  Activation of 5-HT and NR2B contributes to visceral hypersensitivity in irritable bowel syndrome in rats.

Authors:  Ming-Xian Chen; Yu Chen; Rui Fu; Sai-Yue Liu; Qin-Qin Yang; Tang-Biao Shen
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

3.  Irritable bowel syndrome and organic diseases: a comparative analysis of esophageal motility.

Authors:  Thomas Thomaidis; Martin Goetz; Sebastian Paul Gregor; Arthur Hoffman; Elias Kouroumalis; Markus Moehler; Peter Robert Galle; Andreas Schwarting; Ralf Kiesslich
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

4.  Irritable bowel syndrome: the role of food in pathogenesis and management.

Authors:  Paula A Hayes; Marianne H Fraher; Eamonn M M Quigley
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-03

5.  The α isoform of cGMP-dependent protein kinase 1 (PKG1α) is expressed and functionally important in intrinsic primary afferent neurons of the guinea pig enteric nervous system.

Authors:  Zhi S Li; Lin Y Hung; Kara G Margolis; Richard T Ambron; Ying J Sung; Michael D Gershon
Journal:  Neurogastroenterol Motil       Date:  2021-03-03       Impact factor: 3.960

6.  Effects of DA-9701, a novel prokinetic agent, on phosphorylated extracellular signal-regulated kinase expression in the dorsal root ganglion and spinal cord induced by colorectal distension in rats.

Authors:  Sang Pyo Lee; Kang Nyeong Lee; Oh Young Lee; Hang Lak Lee; Dae Won Jun; Byung Chul Yoon; Ho Soon Choi; Se Jin Hwang; Seo Eun Lee
Journal:  Gut Liver       Date:  2013-11-05       Impact factor: 4.519

7.  The severity of irritable bowel syndrome or the presence of fibromyalgia influencing the perception of visceral and somatic stimuli.

Authors:  Fabrizio Tremolaterra; Serena Gallotta; Yvonne Morra; Ennio Lubrano; Carolina Ciacci; Paola Iovino
Journal:  BMC Gastroenterol       Date:  2014-10-17       Impact factor: 3.067

8.  Mild moxibustion decreases the expression of prokineticin 2 and prokineticin receptor 2 in the colon and spinal cord of rats with irritable bowel syndrome.

Authors:  Cili Zhou; Jimeng Zhao; Luyi Wu; Renjia Huang; Yin Shi; Xiaomei Wang; Wen Liao; Jue Hong; Shimin Liu; Huangan Wu
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-12       Impact factor: 2.629

9.  Mast Cell-dependent Mesenteric Afferent Activation by Mucosal Supernatant From Different Bowel Segments of Guinea Pigs With Post-infectious Irritable Bowel Syndrome.

Authors:  Jun Song; Lei Zhang; Tao Bai; Wei Qian; Rui Li; Xiaohua Hou
Journal:  J Neurogastroenterol Motil       Date:  2015-03-30       Impact factor: 4.924

10.  Sensory Adaptation Training or Escitalopram for IBS With Constipation and Rectal Hypersensitivity: A Randomized Controlled Trial.

Authors:  Satish S C Rao; Enrique Coss-Adame; Yun Yan; Askin Erdogan; Jessica Valestin; Deepak Nag Ayyala
Journal:  Clin Transl Gastroenterol       Date:  2021-07-13       Impact factor: 4.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.